These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 3921992

  • 1. Effect of chronic apomorphine on the development of denervation supersensitivity.
    Robin M, Forler C, Palfreyman MG.
    Pharmacol Biochem Behav; 1985 Apr; 22(4):547-51. PubMed ID: 3921992
    [Abstract] [Full Text] [Related]

  • 2. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 3. The effect of a subchronic post-lesion treatment with (-)-deprenyl on the sensitivity of 6-OHDA-lesioned rats to apomorphine and d-amphetamine.
    Spooren WP, Waldmeier P, Gentsch C.
    J Neural Transm (Vienna); 1999 Mar; 106(9-10):825-33. PubMed ID: 10599865
    [Abstract] [Full Text] [Related]

  • 4. Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
    Rioux L, Gaudin DP, Gagnon C, Di Paolo T, Bédard PJ.
    Neuroscience; 1991 Mar; 44(1):75-83. PubMed ID: 1770999
    [Abstract] [Full Text] [Related]

  • 5. Enhancing effect of taurine in the rat caudate spindle. II. Effect of bilateral 6-hydroxydopamine lesions of the nigro-striatal dopamine system.
    Hashimoto-Kitsukawa S, Okuyama S, Aihara H.
    Pharmacol Biochem Behav; 1988 Oct; 31(2):417-23. PubMed ID: 3149745
    [Abstract] [Full Text] [Related]

  • 6. Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats.
    Arnt J, Hyttel J.
    J Neural Transm; 1984 Oct; 60(3-4):205-23. PubMed ID: 6441835
    [Abstract] [Full Text] [Related]

  • 7. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP.
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [Abstract] [Full Text] [Related]

  • 8. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915
    [Abstract] [Full Text] [Related]

  • 9. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A, Ceresoli G, Mandelli V, Parenti M.
    J Pharmacol Exp Ther; 1990 Jun 28; 253(3):950-6. PubMed ID: 2162953
    [Abstract] [Full Text] [Related]

  • 10. Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections.
    Herrera-Marschitz M, Forster C, Ungerstedt U.
    Acta Physiol Scand; 1985 Nov 28; 125(3):519-27. PubMed ID: 3936338
    [Abstract] [Full Text] [Related]

  • 11. Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. II: The striatum of the rat is heterogeneously organized for rotational behaviour.
    Herrera-Marschitz M, Forster C, Ungerstedt U.
    Acta Physiol Scand; 1985 Nov 28; 125(3):529-35. PubMed ID: 3936339
    [Abstract] [Full Text] [Related]

  • 12. Induction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model.
    Lisovoski F, Haby C, Borrelli E, Schleef C, Revel MO, Hindelang C, Zwiller J.
    Brain Res Bull; 1992 May 28; 28(5):697-701. PubMed ID: 1535533
    [Abstract] [Full Text] [Related]

  • 13. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB, Murrin LC, Pfeiffer RF, Deupree JD.
    Clin Neuropharmacol; 1984 May 28; 7(3):247-57. PubMed ID: 6435870
    [Abstract] [Full Text] [Related]

  • 14. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD, Cooper DR, Fleminger S, Rupniak NM, Jenner P, Marsden CD.
    Neuropharmacology; 1984 May 28; 23(5):545-53. PubMed ID: 6539859
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of dopamine metabolism in solid fetal substantia nigra transplants and their terminals in the host striatum.
    Meloni R, Gale K.
    Prog Brain Res; 1990 May 28; 82():467-71. PubMed ID: 2127112
    [No Abstract] [Full Text] [Related]

  • 16. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra.
    Satoh H, Satoh Y, Notsu Y, Honda F.
    Eur J Pharmacol; 1976 Oct 28; 39(2):365-77. PubMed ID: 185065
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentation.
    Oberlander C, Boissier JR.
    J Pharmacol; 1983 Oct 28; 14(4):401-4. PubMed ID: 6423905
    [Abstract] [Full Text] [Related]

  • 19. Does contralateral circling involve action of drugs on hyposensitive striatal dopamine receptors in the hemisphere contralateral to denervation?
    Costall B, Kelly ME, Naylor RJ.
    Neuropharmacology; 1983 Mar 28; 22(3):295-302. PubMed ID: 6133233
    [Abstract] [Full Text] [Related]

  • 20. Possible anomalous behaviour of apomorphine in relation to other dopamine receptor agonists.
    Feenstra MG, Goedemoed JH, Rollema H, Horn AS.
    J Pharm Pharmacol; 1983 Jul 28; 35(7):471-3. PubMed ID: 6136595
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.